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ABSTRACT
Introduction: The human papillomavirus (HPV) has significant public health importance because of its high prevalence, 
mode of transmission, major causative role in cervical cancer, and having effective vaccines. The main thrust of this study 
was to ascertain the level of awareness of HPV and its vaccines among students as well as their attitudes toward receiving 
the vaccines.
Materials and Methods: A descriptive cross‑sectional survey conducted among female undergraduates of the University 
of Ibadan using structured self‑administered questionnaires. The questionnaires sought to obtain information about their 
awareness of HPV, their sexual behavior, previous vaccination, and willingness to access HPV vaccination.
Results: A total of 489 students, with a mean age of 19.7 ± 3.2 years, satisfactorily responded to the survey. Overall, 
411 (84%) had an overall good knowledge about vaccines, 218 (44.6%) recalled that they had been previously vaccinated 
in childhood, and 147 (30.1%) were aware of HPV. Only 66 (13.5%) were aware of HPV vaccines, and 10 (2%) had ever 
been vaccinated against HPV. A majority were willing to get vaccinated if the current price is further reduced.
Conclusion: There is a low level of awareness of HPV and its vaccines among female undergraduates. When available, 
uptake is restricted by cost. There is an urgent need to support public health programs that increase awareness through 
adequate information dissemination on mechanisms of cancer prevention and also to strengthen policy efforts that address 
the barriers of HPV vaccination.
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Introduction
The relationship between cervical cancer and sexual behavior, 
though suspected for more than 100 years, was established 
by epidemiologic studies in the 1960s.[1] However, in the early 
1980s, cervical cancer cells were demonstrated to contain 
the human papillomavirus (HPV) DNA, whereas epidemiologic 
studies showing a consistent association between HPV and 
cervical cancer were published in the 1990s.[1] Cervical 
cancer remains the disease of the developing world as most 
developed countries have made giant strides in curbing its 
occurrence.[2]
Infections with low-risk or non-oncogenic types of HPV, such 
as types 6 and 11, can cause benign or low-grade cervical 
cell abnormalities, genital warts, and laryngeal papilloma, 
whereas high-risk or oncogenic types act as carcinogens in 
the development of cervical cancer and other anogenital 
cancers.[3] HPV is transmitted through intimate skin-to-skin 
contact and can be contacted through the vaginal, anal/or oral 
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routes of sexual activity with documented higher prevalence 
among those engaging in risky sexual behaviors.[3,4]
Over the years, vaccines have been employed as preventive 
measures against several infectious diseases and availability 
of such an approach to prevention of cervical cancer is of 
great benefit to the society. Three HPV vaccines are currently 
marketed internationally and include the bivalent, the 
quadrivalent, and the nonavalent HPV vaccine types. All the 
HPV vaccines are highly immunogenic with more than 99% 
of recipients developing an antibody response to HPV types 
included in the respective vaccines 1 month after completing 
the dose series.[3] Moreover, recent evidences are in favor of 
vaccination regardless of sexual activity or prior exposure 
to HPV.[5] Awareness of HPV, its vaccines, and cervical cancer 
screening has been propagated through several media, but 
studies among the generality of students and market women 
had been reported to be low[6-16] unlike studies conducted 
among health workers and medical students, which reported 
very high levels of awareness.[17,18] The extensive media 
education about HPV and the vaccines pre- and post-licensure 
of the quadrivalent vaccine positively affected the knowledge 
of women about HPV.[19]
The prevalence, mode of transmission, and availability of 
vaccines make HPV of significant public health interest,[20] 
necessitating a need to establish the awareness and 
accessibility of HPV vaccine in our environment. It has 
been documented that HPV vaccination in adolescence 
with continued cervical screening could ultimately lead 
to a 76% lifetime reduction in cervical cancer deaths and 
a 50% reduction in cervical screening abnormalities if high 
coverage of vaccination was achieved,[21,22] but accessibility 
and affordability have remained an important factor to be 
considered in facilitating uptake of the vaccines.[23,24] In a 
report by Hopenhayn et al., in 2007, having knowledge of risk 
factors for cervical cancer significantly predicted willingness 
to accept HPV vaccination.[25] In addition, other studies 
concluded that partner’s approval, history of gynecological 
disease, and one’s mother had experienced cancer, increased 
acceptance of HPV vaccination.[26,27] The main thrust of this 
study was to ascertain the level of awareness of HPV and 
its vaccines among female undergraduates and determine 
factors affecting their willingness to receive them.
Materials and Methods
This was a descriptive cross-sectional survey conducted 
among female undergraduates of the University of Ibadan 
using structured, self-administered questionnaires. The 
University of Ibadan was the first and is the largest University 
in Nigeria with catchment areas covering the entire country. 
The questionnaires, after pretesting and making necessary 
corrections, were distributed to consenting respondents 
in all the female undergraduate hostels in the University. 
The questionnaires were used to obtain information on the 
respondents’ socio-demographic characteristics, awareness 
of cervical cancer and HPV, history of previous vaccination and 
their sexual behavior. Additional information was obtained 
on willingness to get vaccinated and factors affecting such 
decision.
Ethical approval was obtained from the Oyo State Ethics 
Committee, whereas informed consent was provided 
by the respondents. The rights of the participants to 
self-determination, anonymity, and confidentiality were 
ensured, and informed consent was obtained before interview. 
The data obtained were cleaned to ensure correctness and 
completeness. A statistical analysis was done using Statistical 
Package for Social Sciences version 23.0 (SPSS, IBM Inc). 
Frequency tables were generated for socio-demographic 
characteristics, whereas Chi-square test statistics was used 
to test for associations among the variables.
Results
A total of 489 students satisfactorily responded to the 
survey. Their biosocial characteristics and respective 
faculties were presented in Table 1. The mean age of the 
respondents was 19.3 ± 2.6 years ranging between 15 and 
30 years, and although majority were unmarried, 67 (14.1%) 
had been sexually exposed. The mean age of sexual debut 
was 19 years, whereas 44.8% of those who are sexually 
active had multiple sexual partners. Overall, 147 (30.1%) of 
the respondents had ever heard about HPV, whereas only 
66 (13.5%) were aware of a vaccine for HPV [Table 2]. The 
various sources of information on HPV were also shown in 
Table 2. However, 411 (84%) of the respondents had good 
knowledge about vaccines generally, and 218 (44.6%) had 
been previously vaccinated against other infectious diseases 
such as cerebrospinal meningitis whereas only 10 (2.0%) were 
ever vaccinated against HPV [Table 2].
Although only one-third of the respondents were ever 
aware of HPV, it was interesting to note that more than 
half, 269 (55.3%), were willing to receive HPV vaccines. For 
those not wanting to receive the vaccine, diverse reasons 
were provided ranging from being sexually inactive to being 
worried about its safety [Table 3]. Over a third of those who 
were not interested in getting the vaccines had no reasons. 
Table 4 demonstrated the relationship between cost and 
willingness to accept HPV vaccines and showed that more 
people will be willing to take the vaccine if the costs can be 
lowered.
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Discussion
This study revealed a low level of awareness of HPV and its 
vaccines among the female undergraduate students of the 
University of Ibadan. Studies conducted in Turkey showed 
a similar trend in which the level of awareness was found 
to be 24.1% of their study population.[15,28,29] Awareness of 
HPV, HPV vaccines, and cervical cancer screening has been 
propagated through mass media, parents, teachers, and visit 
to health care workers. It has been shown to be influenced by 
the age, society, and background of the individual; beliefs of 
parents, and according to Ojiyi et al., 28% of their respondents 
were aware of the vaccines through the mass media (radio, 
television, and journals).[30] Affecting relatively young women, 
cervical cancer is the largest single cause of years of life lost to 
cancer in the developing world.[31] The deaths of women who 
are in their most productive years have a devastating effect 
on the well-being of their families, resulting, for example., in 
decrease in school attendance and nutritional status among 
their children.[31]
Mass media is the most common source of information 
for our respondents, which is similar to findings from the 
Southeastern part of Nigeria.[17] However, there was an 
increased level of awareness found among 300 and 400 
level students, which could be attributed to an impact of 
the compulsory General Studies course on Reproductive 
Health and Sexually Transmitted Infections piloted in their 
batch. In another study, a review done showed that there 
was a low level of knowledge of both cervical cancer and 
HPV vaccination among women of low and middle income 
countries.[32]
The mean age of sexual debut was 19 years that has 
been shown to be a period of high susceptibility of the 
transformation zone to colonization and as such a major 
risk factor in contracting HPV infection.[20] In another 
study conducted on the awareness and acceptability 
among 150 female medical students and health workers 
in a University Teaching Hospital in Eastern Nigeria, it 
was deduced that the awareness of HPV vaccine was 
74%.[17] However, Hsu et al., in assessing the knowledge and 
beliefs about cervical cancer and HPV among Taiwanese 
undergraduate women, reported limited knowledge about 
cervical cancer and HPV,[27] whereas Perrotte et al., also 
reported a knowledge deficit about HPV and cervical cancer 
in some men and women in Grenada.[33]
The awareness of HPV vaccines among respondents of 13.5% 
is in contrast to 62.7% reported from the Southeastern part of 
Nigeria[17] in a study conducted among female health workers 
such that the higher level of awareness can be attributed to 
the profession and medical education. In a study done by 
Raika Durusoy et al., among 717 students of Ege University, 
in Izmir, Turkey, it was reported that 75.9% had never heard 
of HPV, 23.1% had little knowledge, and only 1.0% had good 
knowledge of HPV, whereas the awareness of HPV vaccines 
in the study population was equally very low.[34]
Table 1: Socio‑demographic characteristics of the participants





30 and above 1 0.2













Agriculture and Fisheries 76 15.5
Art 61 12.5
Social Sciences 53 10.8
Education 49 10.0
Basic Medical Sciences 44 9.0
Law 30 6.1
Pharmacy 15 3.1
Public Health 15 3.1
Technology 11 2.2









22 or later 5 7.5









*STI, Sexually transmitted infection; SD, Standard Deviation
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A study conducted among South African female students 
revealed that although the level of acceptability of HPV 
vaccines is high, the awareness is low.[6] This study also 
compared with a Nigerian study that showed a low level 
of awareness among female undergraduates.[35] In a similar 
vein, an Indian study had reported that 75% of the study 
participants were willing to get vaccinated.[16] However, 
Malaysian university students showed relatively low (48%) 
acceptability of receiving HPV vaccination[36] probably because 
of their remarkably low level of awareness of HPV, HPV 
vaccines, and cervical cancer.[36] Other studies conducted 
among university students reported between 61% and 84% 
acceptability of HPV vaccination.[35,37]
Knowing that most students know the benefits of vaccination 
against many other infectious diseases, extrapolating from 
that, they feel it is okay to get other vaccines.
This finding is of particular public health significance as it 
exposes the need for institution of adequate preventive 
measures against cervical cancer and other HPV related 
infections. The attitude toward the HPV vaccines could 
not be adequately assessed as 86.5% of the respondents 
had never heard about the HPV vaccine. This showed a 
significant knowledge gap in information about the virus 
and poor vaccine coverage among other reasons. The cost 
of the vaccine is relatively high in our environment, being 
higher than the National minimum wage of the workers, 
and this positively contributed to the poor attitude toward 
the HPV vaccination. A similar view on the impact of cost on 
vaccination has been documented in a study from Canada, 
which found 91% of the respondents would get the vaccine 
if it was free, and 72% will get the vaccine if the price was 
set at 100 US dollars.[24]
The possibility of offering vaccination to young girls up to 
age 26 years regardless of sexual activity or prior exposure 
to HPV and even in situations when the patient tested 
positive for HPV DNA[5] gives a wide window for an adequate 
catch-up vaccination for this group of respondents. It 
follows, therefore, that adequate institutional support for 
public health programs that increase awareness through 
appropriate information dissemination will yield positive 
impact. Moreover, educating the populace on mechanisms 
of cancer prevention and at the same time strengthening 
efforts that eliminate the barriers to HPV vaccination will 
ensure reduction in the prevalence of anogenital cancers 
in our environment. HPV vaccination in adolescents with 
continued cervical screening could ultimately lead to a 76% 
lifetime reduction in cervical cancer deaths after many years, 
and a 50% reduction in cervical screening abnormalities if 
high coverage of vaccination was achieved.[22]
Conclusion
The awareness of HPV vaccines is low and where available, 
cost has restricted its uptake. These findings provide 
additional support to strengthening public health programs 
that increase awareness and also policy efforts that address 
the barriers of HPV vaccination.
Table 2: Awareness of HPV and its vaccines
Variable Frequency (n) Percentage






Health talks 18 12.2
Hospital visits 18 12.2
Family and friends 12 8.2
School lectures 22 15.0
Others 1 0.7




Awareness of vaccines for HPV
Yes 66 13.5
No 423 86.5
Ever had HPV vaccines
Yes 10 2.0
No 479 98.0




Aware HPV vaccines are available in Nigeria
Yes 52 10.6
No 437 89.4
Table 3: Willingness to accept HPV vaccination and associated 
factors
Variable Frequency (n) Percentage
Willing to get vaccinated
Yes 269 55.3
No 217 44.7
Reasons for not wanting to get the vaccines (217)
I am not sexually active 51 23.5
I don’t know how to get the vaccine 37 17.1
My doctor did not recommend it 16 7.4
I cannot get cervical cancer 12 5.5
I am worried about its safety 11 5.1
It is too expensive 4 1.8
I am too old to get it 3 1.4
No reason 83 38.2
Oluwasola, et al.: HPV vaccine acceptability among students
37Tropical Journal of Obstetrics and Gynaecology / Volume 36 / Issue 1 / January‑April 2019
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
References
1. Kulshrestha P, Kamal S, Agarwal M, Singh S, Dabral AK. Molecular 
biology of human papillomavirus and its association with the cancer: a 
review. Asian Glob Res J 2014;1:1-10.
2. Kanavos P. The rising burden of cancer in the developing world. Ann 
Oncol 2006;17(Suppl 8):15-23.
3. Center for Disease and Control. Human Papillomavirus. Vol. 11, Center 
for Disease and Control. 2016. Available from: https://www.cdc.gov/
vaccines/pubs/pinkbook/downloads. [Last accessed on 2018 Dec 10].
4. Ma Q, Pan X, Cai G, Yan J, Xu Y, Ono-Kihara M, et al. The 
characteristics of heterosexual STD clinic attendees who practice oral 
sex in zhejiangprovince, China. PLoS One 2013;8:2-7.
5. Human papillomavirus vaccination. Committee Opinion No. 704. 
American College of Obstetricians and Gynecologists. Obstet Gynecol 
2017;129:e173-8.
6. Hoque ME, Ghuman S, Hal GV. Human Papillomavirus vaccination 
acceptability among female university students in South Africa. Asian 
Pac J Cancer Prev 2013;14:4865-9.
7. Bello OO, Oluwasola TAO, Odukogbe AA. Awareness and Attitude 
towards HPV and its vaccines among market women in Bodija market, 
Ibadan. Niger J Med 2016;25:12-7.
8. Ayissi CA, Wamai RG, Oduwo GO, Perlman S, Welty E, Welty T, et al. 
Awareness, acceptability and uptake of human papilloma virus vaccine 
among Cameroonian School-attending female adolescents. J Community 
Health 2012;37:1127-35.
9. Chiang VCL, Wong HT, Yeung PCA, Choi YK, Fok MSY, Mak OI, 
et al. Attitude, acceptability and knowledge of HPV vaccination among 
local university students in Hong Kong. Int J Environ Res Public Health 
2016;13:486.
10. Khan TM, Buksh MA, Rehman IU, Saleem A. Knowledge, attitudes, and 
perception towards human papillomavirus among university students in 
Pakistan. Papillomavirus Res 2016;2:122-7.
11. Kulkarni V, Darshan B, Tandon A, Unnikrishnan B, Iyer S, Kukreja A, 
et al. Awareness and practice regarding cervical cancer prevention among 
female college students of Mangalore city, India. Asian J Pharm Clin 
Res 2015;8:305-7.
12. Makwe CC, Anorlu RI, Odeyemi KA. Human papillomavirus (HPV) 
infection and vaccines: Knowledge, attitude and perception among 
female students at the University of Lagos, Lagos, Nigeria. J Epidemiol 
Glob Health 2012;2:199-206.
13. Medeiros R, Ramada D. Knowledge differences between male and 
female university students about human papillomavirus (HPV) and 
cervical cancer: Implications for health strategies and vaccination. 
Vaccine 2010;29:153-60.
14. Perlman S, Wamai RG, Bain PA, Welty T, Welty E, Ogembo JG. 
Knowledge and awareness of HPV vaccine and acceptability to vaccinate 
in sub-Saharan Africa: A systematic review. PLoS One 2014;9:e90912.
15. Rathfisch G, Gungor I, Uzun E, Keskin O, Tencere Z. Human 
papillomavirus vaccines and cervical cancer: awareness, knowledge, 
and risk perception among Turkish undergraduate students. J Cancer 
Educ 2015;30:116-23.
16. Saha A, Nag Chaudhury A, Bhowmik P, Chatterjee R. Awareness of 
cervical cancer among female students of premier colleges in Kolkata, 
India. Asian Pac J Cancer Prev 2010;11:1085-90.
17. Ojiyi CE, Dike EI, Okeudo C, Nzewuihe AC, Uzoma MJK. Human 
papilloma virus vaccine: Awareness and acceptability amongst female 
medical students and health workers in a university teaching hospital 
in Eastern Nigeria. Niger J SurgSci 2013;23:14-7.
18. Ugwu EO, Obi SN, Ezechukwu PC, Okafor II, Ugwu AO. Acceptability 
of human papilloma virus vaccine and cervical cancer screening among 
female health-care workers in Enugu, Southeast Nigeria. Niger J Clin 
Pract 2013;16:249-52.
19. Lee PWH, Kwan TTC, Fai K, Chan KKL, Young PMC, Lo SST, et al. 
Beliefs about cervical cancer and human papillomavirus (HPV) and 
acceptability of HPV vaccination among Chinese women in Hong Kong. 
Prev Med 2007;45:130-4.
20. Adejuyigbe FF, Balogun BR, Sekoni AO, Adegbola AA. Cervical cancer 
and human papilloma virus knowledge and acceptance of vaccination 
among medical students in Southwest Nigeria. Afr J Reprod Health 
2013;19:140-8.
21. Goldie SJ, O’Shea M, Diaz M, Kim SY. Benefits, cost requirements 
and cost-effectiveness of the HPV16,18 vaccine for cervical cancer 
prevention in developing countries: policy implications. Reprod Health 
Matters 2008;16:86-96.
22. Adams M, Jasani B, Fiander A. Human papilloma virus (HPV) 
prophylactic vaccination: Challenges for public health and implications 
for screening. Vaccine 2007;25:3007-13.
23. Baykal C, Al A, Ugur MG, Cetinkaya N, Attar R, Arioglu P. Knowledge 
and interest of Turkish women about cervical cancer and HPV vaccine. 
Eur J Gynaecol Oncol 2008;29:76-9.
24. Sauvageau C, Duval B, Gilca V, Lavoie F, Ouakki M. Human papilloma 
virus vaccine and cervical cancer screening acceptability among adults 
in Quebec, Canada. BMC Public Health 2007;7:304.
25. Hopenhayn C, Christian A, Christian WJ, Schoenberg NE. Human 
papillomavirus vaccine : knowledge and attitudes in two Appalachian 
Kentucky counties. Cancer Causes Control 2007;16:627-34.
26. Kwan TTC, Chan KKL, Yip AMW, Tam KF, Cheung ANY, Lo SST, 
et al. Acceptability of human papillomavirus vaccination among Chinese 
women: Concerns and implications. BJOG 2009;116:501-10.
27. Hsu YY, Fetzer SJ, Hsu KF, Chang YY, Huang CP, Chou CY. Intention 
to obtain human papillomavirus vaccination among taiwanese 
undergraduate women. Sex Transm Dis 2009;36:686-92.
28. Ozyer S, Uzunlar O, Ozler S, Kaymak O, Baser E, Gungor T, et al. 
Awareness of Turkish female adolescents and young women about HPV 
and their attitudes towards HPV vaccination. Asian Pac J Cancer Prev 
2013;14:4877-81.
Table 4: Relationship between cost and willingness to accept 
HPV vaccines
With the current price of the 
vaccine, would you be willing 
to get it?
Total
Would you be interested in 
getting the HPV vaccines
YES NO
YES 78 230 308
NO 10 171 181
Total 88 401 489
OR=5.8; 95% CI=2.92‑11.53
If you could get the HPV 
vaccines free or at a lower 
cost, would you want to be 
vaccinated?
Total
Would you be interested in 
getting the HPV vaccines
YES NO
YES 257 44 301
NO 56 132 188
Total 313 176 489
OR=13.77; 95% CI=8.80‑21.53
Oluwasola, et al.: HPV vaccine acceptability among students
38 Tropical Journal of Obstetrics and Gynaecology / Volume 36 / Issue 1 / January‑April 2019
29. Yilmazel G, Duman NB. Knowledge, attitudes and beliefs about cervical 
cancer and human papilloma virus vaccination with related factors in 
Turkish university students. Asian Pac J Cancer Prev 2014;15:3699-704.
30. Ojiyi EC, Okeudo C, Dike EI, Anolue FC, Onyeka U, Audu BM, et al. 
The prevalence and predictors of human papilloma virus infection of 
the cervix at a university teaching hospital in northern Nigeria. Internet 
J Gynecol Obstet 2012;16:1-19.
31. Agosti JM, Goldie SJ. Introducing HPV Vaccine in Developing Countries 
— Key Challenges and Issues. N Engl J Med 2007;356:1908-10.
32. Hopkins TG, Wood N. Female human papillomavirus (HPV) vaccination: 
Global uptake and the impact of attitudes. Vaccine 2013;31:1673-9.
33. Perrotte N, Gomez A, Mason G, Stroup D. An assessment of knowledge, 
attitudes and behaviourregarding the human papilomavirus. West Indian 
Med J 2012;61:58-63.
34. Durusoy R, Yamazhan M, Taşbakan MI, Ergin I, Aysin M, 
Pullukçu H, et al. HPV vaccine awareness and willingness of first-year 
students entering university in Western Turkey. Asian Pac J Cancer Prev 
2010;11:1695-701.
35. Iliyasu Z, Abubakar IS, Aliyu MH, Galadanci HS. Cervical cancer risk 
perception and predictors of human papilloma virus vaccine acceptance 
among female university students in northern Nigeria. J Obstet Gynaecol 
2010;30:857-62.
36. Wong LP, Sam IC. Ethnically diverse female university students’ 
knowledge and attitudes toward human papillomavirus (HPV), HPV 
vaccination and cervical cancer. Eur J Obstet Gynecol Reprod Biol 
2010;148:90-5.
37. Gerend MA, Lee SC, Shepherd JE. Among underserved women. Sex 
Transm Dis 2007;34:468-71.
